skip to main content

DMF – Flushing Management — SCE Neurology MCQ

Instant feedback + full explanation. One question, done properly.

HardMultiple Sclerosis & CNS InflammationDMF – Flushing ManagementSCE Neurology

A patient develops troublesome flushing and gastrointestinal discomfort during the first week after dimethyl fumarate was increased to 240 mg twice daily. There is no rash, anaphylaxis or laboratory abnormality. Which strategy is authorised to improve early tolerability?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: ATake with food; use 120 mg twice daily temporarily, then resume 240 mg twice daily within one month

Food can improve dimethyl fumarate tolerability. A temporary reduction to 120 mg twice daily is permitted, but the recommended 240 mg twice-daily maintenance dose should be resumed within one month. Indefinite high-dose aspirin premedication is not the authorised solution, and once-daily, alternate-day or prolonged interruption schedules risk ineffective treatment.

Reference: Dimethyl fumarate Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/15504/smpc